Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 130,338
  • Shares Outstanding, K 34,390
  • Annual Sales, $ 0 K
  • Annual Income, $ -29,820 K
  • EBIT $ -31 M
  • EBITDA $ -31 M
  • 60-Month Beta 1.58
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.14

Options Overview Details

View History
  • Implied Volatility 191.85% ( +1.75%)
  • Historical Volatility 38.22%
  • IV Percentile 95%
  • IV Rank 44.79%
  • IV High 384.69% on 12/23/24
  • IV Low 35.37% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 33
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 9,789
  • Open Int (30-Day) 15,098

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.20
  • Low Estimate -0.39
  • Prior Year -0.26
  • Growth Rate Est. (year over year) -15.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.60 +5.56%
on 12/20/24
4.66 -18.37%
on 12/10/24
-0.68 (-15.18%)
since 11/26/24
3-Month
3.60 +5.56%
on 12/20/24
5.31 -28.44%
on 11/06/24
-0.64 (-14.41%)
since 09/26/24
52-Week
3.60 +5.56%
on 12/20/24
5.59 -32.02%
on 05/29/24
-0.24 (-5.94%)
since 12/26/23

Most Recent Stories

More News
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

Achieve Life Sciences announces Mark Oki as Chief Financial Officer to enhance financial strategy and support nicotine dependence treatment development.Quiver AI SummaryAchieve Life Sciences, Inc. has...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Announces Successful FDA End-of-Phase 2 Meeting for Cytisinicline as Potential Treatment for Vaping Cessation

Achieve Life Sciences reports FDA alignment on Phase 3 trial for cytisinicline, targeting vaping cessation amid public health concerns.Quiver AI SummaryAchieve Life Sciences, Inc. has announced the successful...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Participate in Upcoming Investor Conferences in London and New York

Achieve Life Sciences announced CEO participation in two investor conferences regarding cytisinicline's development for nicotine dependence treatment.Quiver AI SummaryAchieve Life Sciences, Inc., a late-stage...

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

ACHV : 3.80 (+0.26%)
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 7, 2024

ACHV : 3.80 (+0.26%)
Achieve Life Sciences President and CMO, Dr. Cindy Jacobs, Speaks at FDA and NIH Smoking Cessation Public Meeting

ACHV : 3.80 (+0.26%)
Achieve Life Sciences Promotes Jaime Xinos to Chief Commercial Officer to Advance Commercial Readiness of Cytisinicline

ACHV : 3.80 (+0.26%)

Business Summary

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc.,...

See More

Key Turning Points

3rd Resistance Point 3.94
2nd Resistance Point 3.89
1st Resistance Point 3.84
Last Price 3.80
1st Support Level 3.74
2nd Support Level 3.69
3rd Support Level 3.64

See More

52-Week High 5.59
Fibonacci 61.8% 4.83
Fibonacci 50% 4.60
Fibonacci 38.2% 4.36
Last Price 3.80
52-Week Low 3.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar